# Submission for OMB Review; Comment Request
**AGENCY:**
Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)), Department of Defense (DoD).
**ACTION:**
30-Day information collection notice.
**SUMMARY:**
The DoD has submitted to the Office of Management and Budget (OMB) for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act.
**DATES:**
Consideration will be given to all comments received by April 17, 2024.
**ADDRESSES:**
Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to *www.reginfo.gov/public/do/PRAMain.* Find this particular information collection by selecting “Currently under 30-day Review—Open for Public Comments” or by using the search function.
**FOR FURTHER INFORMATION CONTACT:**
Mr. Reginald Lucas, 571-372-7574, or *[email protected]* .
**SUPPLEMENTARY INFORMATION:**
*Title; Associated Form; and OMB Number:* Fielding Successful Medical Products Survey; OMB Control Number 0720-VOIP.
*Type of Request:* New.
*Number of Respondents:* 50.
*Responses per Respondent:* 1.
*Annual Responses:* 50.
*Average Burden per Response:* 30 minutes.
*Annual Burden Hours:* 25.
*Needs and Uses:* As part of 59th Medical Wing's Science & Technology, Technology Transfer and Transition (59 MDW/ST-T3) Office's continuous process improvement effort, this proposed information collection will gather feedback from companies which have successfully developed and marketed commercially-available medical products to the DoD over the last five (5) years. The questionnaire elicits information about (a) funding streams, processes, ideas, partnerships, and pathways, (b) Food & Drug Administration (FDA) approval/clearance, (c) teaming arrangements, management strategies, and leadership approaches, and (d) barriers and enablers to marketing to the DoD. By performing this market analysis, we aim to develop actionable, data-driven recommendations for improving acquisition of innovative medical solutions. An analysis of responses permits a clear understanding how the DoD can influence, emulate, and facilitate successful production and provisioning of new/novel medical products (capabilities) to address existing requirements or enhance existing medical/health capabilities. Specifically, this effort will support the DHA's mission of driving innovative solutions to improve health and build readiness.
*Affected Public:* Individuals or households.
*Frequency:* On occasion.
*Respondent's Obligation:* Voluntary.
*OMB Desk Officer:* Ms. Jasmeet Seehra.
You may also submit comments and recommendations, identified by Docket ID number and title, by the following method:
• *Federal eRulemaking Portal:**http://www.regulations.gov.* Follow the instructions for submitting comments.
*Instructions:* All submissions received must include the agency name, Docket ID number, and title for this *Federal Register* document. The general policy for comments and other submissions from members of the public is to make these submissions available for public viewing on the internet at *http://www.regulations.gov* as they are received without change, including any personal identifiers or contact information.
*DOD Clearance Officer:* Mr. Reginald Lucas.
Requests for copies of the information collection proposal should be sent to Mr. Reginald Lucas at *[email protected].*
Dated: March 12, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.